ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

by Impact Journals LLCUpregulated genes and pathways enriched in glioblastoma cell lines treated with gartisertib combined with TMZ+RT. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28

Updated on: May 11,2024 3

ATR inhibition using gartisertib in patient-derived glioblastoma cell lines

by Impact Journals LLCUpregulated genes and pathways enriched in glioblastoma cell lines treated with gartisertib combined with TMZ+RT. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28

Updated on:May 11,2024 3

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on: January 08,2024 13

To improve a promising cancer drug, cut it in half

by Ian Haydon,University of Washington School of MedicineNeoleukin-2/15 can be split into two fragments that reconstitute its activity when combined. a, Splitting strategy for Neo-2/15. Structur

Updated on:January 08,2024 13

The impact of lysine crotonylation on cardiac injury and glioblastoma immunology

Updated on: June 26,2024 0

The impact of lysine crotonylation on cardiac injury and glioblastoma immunology

Updated on:June 26,2024 0

PSMA PET scanning can improve decision making for prostate cancer treatment

bySociety of Nuclear MedicineHeat map of prostate bed PSMA PET recurrences distribution in the miTr N0 Mo cohort (n=127 patients) mapped on a template patient’s anatomy (the green contour repres

Updated on: December 17,2023 10

PSMA PET scanning can improve decision making for prostate cancer treatment

bySociety of Nuclear MedicineHeat map of prostate bed PSMA PET recurrences distribution in the miTr N0 Mo cohort (n=127 patients) mapped on a template patient’s anatomy (the green contour repres

Updated on:December 17,2023 10

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on: December 18,2023 12

Cancer prevention experts provide top tips for reducing cancer risk

by Rutgers Cancer Institute of New JerseyCredit: Pixabay/CC0 Public DomainMany forms of cancer are preventable. Although risk factors such as age or genetics cannot be changed, other risk factors for

Updated on:December 18,2023 12

Survival rates high for children, teens with melanoma

by Lori SolomonSurvival rates for children and adolescents with melanomas are high, according to a study published online Dec. 9 in theJournal of the American Academy of Dermatology.Mary-Ann El

Updated on: December 21,2023 9

Survival rates high for children, teens with melanoma

by Lori SolomonSurvival rates for children and adolescents with melanomas are high, according to a study published online Dec. 9 in theJournal of the American Academy of Dermatology.Mary-Ann El

Updated on:December 21,2023 9

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,

Updated on: October 23,2023 264

Belzutifan outperforms everolimus in advanced kidney cancer treatment

byDana-Farber Cancer InstituteCredit: CC0 Public DomainBelzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer,

Updated on:October 23,2023 264

Study shows AI improves accuracy of skin cancer diagnoses

by Krista Conger,Stanford UniversityCredit: CC0 Public DomainA new study led by researchers at Stanford Medicine finds that computer algorithms powered by artificial intelligence based on deep l

Updated on: April 30,2024 0

Study shows AI improves accuracy of skin cancer diagnoses

by Krista Conger,Stanford UniversityCredit: CC0 Public DomainA new study led by researchers at Stanford Medicine finds that computer algorithms powered by artificial intelligence based on deep l

Updated on:April 30,2024 0

Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&

Updated on: October 17,2023 20

Multicenter Review Supports TKI Use in Patients With mRCC and Bone Metastases

September 20, 2022Megan HollaschAn analysis of patterns of care and outcomes for patients with metastatic renal cell carcinoma with bone metastases supported the role of TKIs as the standard of care.&

Updated on:October 17,2023 20

Capturing immunotherapy response in a blood drop

byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci

Updated on: October 14,2023 296

Capturing immunotherapy response in a blood drop

byJohns Hopkins University School of MedicineAn impressionist painting of a liquid biopsy. Credit: Valsamo Anagnostou x DALL-E, openAILiquid biopsies are blood tests that can serially measure ci

Updated on:October 14,2023 296

Venetoclax/Atezolizumab/Obinutuzumab Elicits Durable Responses in Richter Transformation

June 23, 2023Ryan ScottThe combination of venetoclax, atezolizumab, and obinutuzumab elicited responses and prolonged time progression, in patients with chronic lymphocytic leukemia with Richter trans

Updated on: October 15,2023 76

Venetoclax/Atezolizumab/Obinutuzumab Elicits Durable Responses in Richter Transformation

June 23, 2023Ryan ScottThe combination of venetoclax, atezolizumab, and obinutuzumab elicited responses and prolonged time progression, in patients with chronic lymphocytic leukemia with Richter trans

Updated on:October 15,2023 76

Iruplinalkib Improves PFS Vs Crizotinib in Locally Advanced or Metastatic ALK+ NSCLC

September 10, 2023Kristi RosaTreatment with iruplinalkib significantly improved progression-free survival and produced a higher objective response rate compared with crizotinib in patients with ALK TK

Updated on: October 11,2023 56

Iruplinalkib Improves PFS Vs Crizotinib in Locally Advanced or Metastatic ALK+ NSCLC

September 10, 2023Kristi RosaTreatment with iruplinalkib significantly improved progression-free survival and produced a higher objective response rate compared with crizotinib in patients with ALK TK

Updated on:October 11,2023 56